C. Ruiz

Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification

J. Ballarín, I. Dasilva, M. Díaz-Encarnación, 2016, Expert opinion on pharmacotherapy.

Adynamic bone disease: from bone to vessels in chronic kidney disease.

P. Ureña, D. Goldsmith, I. Dasilva, 2014, Seminars in nephrology.

Preparation of (R)- and (S)-γ-amino-β-hydroxypropylphosphonic acid from glycine

M. Ordóñez, R. D. L. Cruz-Cordero, C. Ruiz, 2003 .

Vitamin D Receptor and Interaction with DNA: From Physiology to Chronic Kidney Disease

S. Pilz, I. Dasilva, J. Bover, 2016 .

Thermostability and molecular encapsulation within an engineered caged protein scaffold

Sierin Lim, C. Ruiz, Szu‐Wen Wang, 2008, Biotechnology and bioengineering.

Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment

C. Nicolau, L. Quintana, E. Poch, 2022, Nephron.